BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goll R, Heitmann R, Moe ØK, Carlsen K, Florholmen J. Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis. PLoS One 2019;14:e0224895. [PMID: 31790426 DOI: 10.1371/journal.pone.0224895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 D'Amico F, Rubin DT, Kotze PG, Magro F, Siegmund B, Kobayashi T, Olivera PA, Bossuyt P, Pouillon L, Louis E, Domènech E, Ghosh S, Danese S, Peyrin-Biroulet L. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterol J 2021;9:451-60. [PMID: 33961734 DOI: 10.1002/ueg2.12069] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Osredkar J, Kurent T, Fabjan T, Kumer K, Božnar Alič E, Drobne D. The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease. Biochem Med (Zagreb) 2021;31:020707. [PMID: 33927557 DOI: 10.11613/BM.2021.020707] [Reference Citation Analysis]
3 Xiang BJ, Jiang M, Sun MJ, Dai C. Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Visc Med 2021;37:338-48. [PMID: 34722717 DOI: 10.1159/000514196] [Reference Citation Analysis]
4 Lee JM, Jang JH, Ryu JH, Yoo J, Lee BI, Kim SJ, Oh EJ. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease. PLoS One 2021;16:e0255974. [PMID: 34383847 DOI: 10.1371/journal.pone.0255974] [Reference Citation Analysis]